Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > From Quarterly MD&A

<< Previous

Bullboard Posts

Next >>

Comment by Sunvalleyon Dec 01, 2021 5:18am

569 Views

Post# 34183644

RE:From Quarterly MD&A

Excellent information Oden6570. Thank you for posting . This little Company is clearly going where no biotech has ever gone before and the results are astounding.I do not see how the Medical community can ignore Theralase too much longer without wanting to get in on the action. In my opinion our future is assured. Only a matter of time now.

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?